1.Mechanisms of Traditional Chinese Medicine in Regulating Angiogenesis: A Review
Zeming ZHANG ; Lanchun LIU ; Qiyang LI ; Xuan SUN ; Ruoqi ZHANG ; Yiyao ZHANG ; Jie WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(11):277-286
Angiogenesis, as a core mechanism for maintaining tissue perfusion and repairing ischemic injury, plays a crucial role in ischemic diseases such as coronary heart disease and peripheral arterial disease. Traditional Chinese medicine(TCM), with its advantages of multi-target and synergistic regulation, provides a unique perspective for therapeutic angiogenesis. Based on this, this article intends to delve into the synergistic effects of key signaling pathways, including vascular endothelial growth factor(VEGF)/VEGF receptor(VEGFR), Notch, phosphoinositide 3-kinase/ protein kinase B/mammalian target of rapamycin(PI3K/Akt/mTOR), and angiopoietin/endothelial TEK tyrosine kinase(Ang/Tie2), and elucidate the driving mechanisms of endothelial cell metabolic reprogramming and exosome-mediated intercellular communication within this process. Based on existing literature, it summarizes the microenvironment-dependent and bidirectional regulatory characteristics of natural active components of TCM(such as terpenes, tanshinones, and flavonoids) on angiogenesis. Furthermore, it systematically discusses how classical TCM formulas achieve blood vessel formation and functional maturation by protecting the neurovascular units, recruiting pericytes, and remodeling the microenvironment. Current evidence highlights the advantages of multi-target synergy and temporal regulation in TCM, but also reveals challenges such as high heterogeneity and a lack of functional evaluations and high-quality clinical trials. Future efforts should integrate multi-omics to decipher network mechanisms, optimize formula compatibility, and conduct multicenter studies to promote the development of innovative preparations. This review highlights the academic value of TCM in angiogenesis, provides an evidence base for treating ischemic diseases, and supports multidisciplinary integration and innovation.
2.Changes in the composition of immune cells in the tumor microenvironment of MMTV-PyMT breast cancer mice at different ages
Xiaochen LIN ; Lihong GONG ; Yingxue GUO ; Lu JIN ; Mengyun CHEN ; Penghao WANG ; Cui YU ; Huiying FU ; Qiyang SHOU
Acta Laboratorium Animalis Scientia Sinica 2025;33(7):935-946
Objective This study aimed to investigate the tumorigenic properties of MMTV-PyMT breast cancer transgenic mice at different ages(in weeks)and the changes in the composition of immune cells in the tumor microenvironment.Methods Eight groups of 4,6,8,10,12,14,16 and 18 weeks of age MMTV-PyMT female mice(FVB mice as the background)and one group of 8 weeks of FVB female mice were prepared for routine blood testing,the pathological changes of the mammary gland and lung metastases were observed by histopathological sections,and the immune cells in blood,spleen,and tumor were analyzed by flow cytometry.Results MMTV-PyMT mice showed adenular ductal lesions at 4~6 weeks of age;the ductal portion expanded to the growth boundary at 8~9 weeks of age,and then gradually broke through the glandular boundary to form early breast cancer at 8~12 weeks of age,and advanced breast cancer at 10~14 weeks of age.At 12 weeks of age,metastases were visible in the lungs of some mice,and at 14 weeks of age,the number of metastases in the lungs increased significantly.As the age of the mice increased,the number of white blood cells,neutrophils,and platelets in their blood increased gradually,while the lymphocytes and erythrocytes showed a gradual downward trend.Flow cytometry showed that with the increase in age,the proportion of T cells in the spleen and tumor gradually decreased,the MDSCs in the blood,spleen,and tumor gradually increased,and the NK cells in the tumor also gradually increased.Conclusions This study analyzed routine blood tests,pathology,and immune cells in the tissues of MMTV-PyMT mouse models of different weeks of age,providing a novel perspective on the dynamic alterations of the tumor immune microenvironment during the malignant progression of breast cancer.
3.Research progress on applications for the mouse brain atlas and its analysis techniques
Mingmin PAN ; Qiyang WANG ; Guangxin YUE
Acta Laboratorium Animalis Scientia Sinica 2025;33(7):1053-1063
Mice are a core model organism in neuroscience and are undergoing a technological transition in whole-brain atlas construction,as researchers shift from traditional anatomical approaches to multidimensional molecular-level analysis.This marks a new phase in brain research method ology,characterized by higher resolution and systemic integration.Spatial transcriptomics technologies have significantly advanced the biological depth of neuroscience studies,offering novel paradigms for exploring dynamic neural circuit evolution and cellular diversity in the brain.By combining traditional anatomical localization,single-cell molecular connectomics,and functional imaging for macroscopic dynamic tracking,brain atlas research achieves"molecule-circuit-behavior"tri-level integration,thereby constructing molecular regulatory networks underlying dynamic neural circuit remodeling.However,current challenges persist in technical integration.Reference brain atlases hold great promise for elucidating brain homeostasis mechanisms,identifying abnormal circuit metabolic features in neurological disorders(e.g.,anxiety),and screening therapeutic targets.Future brain atlas research must advance multimodal technology fusion and cross-dimensional data integration to achieve precise mapping from static structures to dynamic functional networks,and thus provide revolutionary tools for neuroscience.
4.Changes in the composition of immune cells in the tumor microenvironment of MMTV-PyMT breast cancer mice at different ages
Xiaochen LIN ; Lihong GONG ; Yingxue GUO ; Lu JIN ; Mengyun CHEN ; Penghao WANG ; Cui YU ; Huiying FU ; Qiyang SHOU
Acta Laboratorium Animalis Scientia Sinica 2025;33(7):935-946
Objective This study aimed to investigate the tumorigenic properties of MMTV-PyMT breast cancer transgenic mice at different ages(in weeks)and the changes in the composition of immune cells in the tumor microenvironment.Methods Eight groups of 4,6,8,10,12,14,16 and 18 weeks of age MMTV-PyMT female mice(FVB mice as the background)and one group of 8 weeks of FVB female mice were prepared for routine blood testing,the pathological changes of the mammary gland and lung metastases were observed by histopathological sections,and the immune cells in blood,spleen,and tumor were analyzed by flow cytometry.Results MMTV-PyMT mice showed adenular ductal lesions at 4~6 weeks of age;the ductal portion expanded to the growth boundary at 8~9 weeks of age,and then gradually broke through the glandular boundary to form early breast cancer at 8~12 weeks of age,and advanced breast cancer at 10~14 weeks of age.At 12 weeks of age,metastases were visible in the lungs of some mice,and at 14 weeks of age,the number of metastases in the lungs increased significantly.As the age of the mice increased,the number of white blood cells,neutrophils,and platelets in their blood increased gradually,while the lymphocytes and erythrocytes showed a gradual downward trend.Flow cytometry showed that with the increase in age,the proportion of T cells in the spleen and tumor gradually decreased,the MDSCs in the blood,spleen,and tumor gradually increased,and the NK cells in the tumor also gradually increased.Conclusions This study analyzed routine blood tests,pathology,and immune cells in the tissues of MMTV-PyMT mouse models of different weeks of age,providing a novel perspective on the dynamic alterations of the tumor immune microenvironment during the malignant progression of breast cancer.
5.Research progress on applications for the mouse brain atlas and its analysis techniques
Mingmin PAN ; Qiyang WANG ; Guangxin YUE
Acta Laboratorium Animalis Scientia Sinica 2025;33(7):1053-1063
Mice are a core model organism in neuroscience and are undergoing a technological transition in whole-brain atlas construction,as researchers shift from traditional anatomical approaches to multidimensional molecular-level analysis.This marks a new phase in brain research method ology,characterized by higher resolution and systemic integration.Spatial transcriptomics technologies have significantly advanced the biological depth of neuroscience studies,offering novel paradigms for exploring dynamic neural circuit evolution and cellular diversity in the brain.By combining traditional anatomical localization,single-cell molecular connectomics,and functional imaging for macroscopic dynamic tracking,brain atlas research achieves"molecule-circuit-behavior"tri-level integration,thereby constructing molecular regulatory networks underlying dynamic neural circuit remodeling.However,current challenges persist in technical integration.Reference brain atlases hold great promise for elucidating brain homeostasis mechanisms,identifying abnormal circuit metabolic features in neurological disorders(e.g.,anxiety),and screening therapeutic targets.Future brain atlas research must advance multimodal technology fusion and cross-dimensional data integration to achieve precise mapping from static structures to dynamic functional networks,and thus provide revolutionary tools for neuroscience.
6.Prone position lateral lumbar interbody fusion combined with posterior pedicle screw fixation for the treatment of lumbar degenerative diseases
Yonghui ZHAO ; Sheng LU ; Qiang YANG ; Weichao LI ; Jiayu CHEN ; Qiyang WANG ; Tiannan ZOU ; Kun HUANG ; Jie LIU ; Hui ZHONG
Chinese Journal of Orthopaedics 2024;44(17):1151-1158
Objective:To explore the feasibility and clinical efficacy of prone transpsoas lateral interbody fusion (PTP LIF) combined with posterior pedicle screw fixation for the treatment of lumbar degenerative diseases in the prone position.Methods:A total of 23 patients who underwent LLIF in the prone position at the First People's Hospital of Yunnan Province between March 2023 and October 2023 were retrospectively analyzed. The cohort comprised 9 males and 14 females, with a mean age of 55.5±8.8 years (range, 41-70 years). The clinical diagnoses included intervertebral disc herniation with endplate inflammation (3 cases), lumbar spinal stenosis (13 cases), lumbar spondylolisthesis (5 cases), and lumbar instability (2 cases). The surgical segments involved L 3, 4 (15 cases), L 4, 5 (6 cases), and L 3-L 5 (2 cases), with 21 cases involving a single segment and 2 cases involving double segments. The disc height and lumbar lordosis Angle before and after surgery were compared. Lower back pain was evaluated using the visual analogue scale (VAS), while lumbar spine function was assessed via the Oswestry Disability Index (ODI). Clinical efficacy was evaluated according to the modified MacNab criteria at the last follow-up. Results:All surgeries were successfully completed. The operation time was 120.2±21.4 min (range, 90-175 min), intraoperative blood loss was 131.1±40.8 ml (range, 60-200 ml), and the hospital stay was 6.2±1.6 days (range, 4-10 days). Follow-up was obtained for all 23 cases, with the follow-up time being 9.6±2.2 months (range, 6-13 months). One case of endplate damage occurred during surgery, two cases of transient psoas muscle weakness occurred postoperatively, and one case of lower limb pain and numbness was reported; no cases of wound infection or delayed healing were observed. The postoperative disc height improved compared to preoperative (6.8±1.9 mm; F=66.618, P<0.001). There was no statistically significant difference between 3 months postoperative (11.1±1.2 mm) and immediately postoperative (12.2±1.2 mm; P>0.05), but there was a statistically significant difference between the last follow-up (10.7±1.1 mm) and immediately postoperative ( P<0.05). The postoperative lumbar lordosis angle improved compared to preoperative (35.3°±5.4°; F=19.465, P<0.001), with no statistically significant difference between 3 months postoperative (44.1°±5.4°) and immediately postoperative (47.8°±6.6°; P>0.05), but there was a statistically significant difference between the last follow-up (43.2°±5.3°) and immediately postoperative ( P<0.05). The postoperative VAS score improved compared to preoperative (6.3±1.1 points; F=79.931, P<0.001), and the last follow-up (1.1±1.1 points) showed further improvement compared to 3 months postoperative (1.7±1.4 points; P<0.05). The postoperative ODI improved compared to preoperative (69.9%±7.4%; F=592.392, P<0.001), with 3 months postoperative (23.1%±3.1%) showing improvement compared to 1 month postoperative (29.2%±3.1%), and the last follow-up (17.5%±3.6%) showing further improvement compared to 3 months postoperative ( P<0.05). At the last follow-up, the modified MacNab criteria were: excellent in 16 cases, good in 5, fair in 2, with an excellent and good rate of 91% (21/23); 7 cases of cage subsidence were observed, with no cases of internal fixation loosening. Conclusion:PTP LIF combined with pedicle screw fixation for the treatment of lumbar degenerative diseases is safe and effective, with satisfactory short-term postoperative outcomes.
7.Multidimensional screening of Astragalus membranaceus small molecules to mitigate carbon ion radiation-induced bystander effects
Zhang LIYING ; Zhang YIMING ; Li YANGYANG ; Li QIYANG ; Zhang SHANGZU ; Miao ZHIMING ; He JINPENG ; Zhou TING ; Yang GENGQIANG ; Wang XIN ; Wang JUFANG ; Liu YONGQI
Journal of Pharmaceutical Analysis 2024;14(10):1531-1534
Existing studies have shown that Astragalus membranaceus(AM)and its active ingredients astragalus polysaccharides,oninon,and astragalus methyl glycosides can attenuate X-ray radiation-induced injury.However,there are no studies on how isoliquiritigenin(ISL)attenuate the bystander effect of bone marrow mesenchymal stem cells(BMSCs)induced by carbon ion radiation therapy for lung cancer.This study aimed to investigate the AM-derived small molecule ISL to enhance radiotherapy sensitivity by attenuating the carbon ion radiation-induced bystander effect(RIBE)in BMSCs to elucidate its mecha-nism of action.In this study,we established a C57BL/6 mouse lung cancer transplantation tumor model in vivo and a co-culture model of A549 cells and BMSCs in vitro,and the models were successfully treated with carbon ions.In further work,we used flow cytometry,immunofluorescence,Western blot,enzyme-linked immunosorbent assay(ELISA),inhibitor,short hairpin RNA(shRNA),Cell Counting Kit-8(CCK-8),and other methods to illustrate the mechanism.In the next experiments,we found that ISL combined with carbon ion radiotherapy had a significant anti-tumor effect and protected BMSCs from radiation damage.The aim of this study was to investigate the potential of ISL in enhancing the sensitivity of lung cancer cells to radiotherapy and attenuating RIBE in both in vitro and in vivo settings.Traditional Chinese medicine combined with radiation therapy is a promising and innovative treatment for non-small cell lung cancer.These results establish a theoretical foundation for further clinical development of ISL as a potential radiosensitizer option.
8.An intervention study of Orff-music therapy for long-term hospitalized patients with schizophrenia
Tianle WANG ; Rizhao LI ; Qiyang HUANG ; Daming LIU ; Dakai XIA ; Ting FENG ; Aroufujiang YIERXIATI ; Jieyi WU ; Bin SUN ; Xinyan ZHENG ; Yingchun DAI
Chinese Journal of Nervous and Mental Diseases 2024;50(3):135-139
Objective This research aims to investigate the impact of Orff music therapy on long-term schizophrenic patients in hospitals.Methods The study was a randomized,single-blind controlled trial conducted from April,2023 to September,2023.From April to September 2023,sixty-eight individuals diagnosed with persistent schizophrenia were enrolled and evenly distributed into a pair of cohorts:a treatment group of thirty-four people receiving the intervention,and an equal number forming the control group for comparative purposes.Individuals enrolled in the experimental arm of the study were administered Orff-music therapy alongside routine rehabilitation treatment across a span of two months.For a period of 8 weeks,the control group was given only standard rehabilitation treatment,whereas the research group underwent Orff-music therapy in addition to the standard rehabilitation treatment.Results Before treatment,there were no significant differences in the positive and negative symptoms scale(PANSS),the inpatient psychosis rehabilitation observe scale(IPROS)and the personal and social performance scale(psp)between two groups.After intervention,the PANSS showed that the changes were better in the study group than in the control group in 3 indicators:negative symptoms(-3.20±4.13 vs.-0.17±2.43,P<0.001),general symptoms(-2.79±3.83 vs.-0.17±2.99,P=0.003)and the total scores(-5.88±6.36 vs.0.00±4.08,P<0.001),but not in positive symptoms(P>0.05).The IPROS showed that the performances of patients in the study group were better than the control group in terms of participation in work therapy(-0.82±2.08 vs.0.23±2.10,P=0.041),socialization(-0.59±1.94 vs.0.53±1.69,P=0.014)and ability to live(-0.94±2.50 vs.0.15±1.48,P=0.033),the changes in scores before and after the intervention were significantly different when compared to the control group.The PSP showed that the changes in scores before and after the treatment of the study group was better than the control group in terms of social activity[0(-1,0)vs.0(0,0),P=0.011],and self-care[0(-1,0)vs.0(-0.25,0),P=0.012]were better than the control group.Conclusion For long-term hospitalized patients with chronic schizophrenia.Orff-music therapy can be a powerful tool for alleviating mental issues,fostering social functioning,and enhancing rehabilitation results.
9.Distribution characteristics and drug resistance of 267 strains in intensive care unit
Qiyang XIE ; Yi WANG ; Yanming LOU ; Hanjian LOU ; Junhong HE
China Pharmacist 2024;27(5):848-854
Objective To explore the distribution characteristics and drug resistance of 267 strains of pathogenic bacteria in the intensive care unit.Methods 180 specimens sent for examination from 180 patients admitted to the intensive care unit of Yiwu Central Hospital who developed hospital-acquired infections from January 2021 to November 2023 were collected,and the sites of infection and the sources of specimens of patients with hospital-acquired infections were counted.The distribution characteristics of the patient's protozoa were analyzed,and the drug resistance of major Gram-positive bacteria(Staphylococcus aureus,Staphylococcus epidermidis)and Gram-negative bacteria(Escherichia coli,Pseudomonas aeruginosa,and Klebsiella pneumoniae)was analyzed in combination with drug sensitivity assessment results.Results Among the 180 patients with hospital-acquired infections,pulmonary and urinary tract infections accounted for a relatively high proportion,and sputum and urine specimens accounted for a relatively high proportion of the samples submitted for examination.180 specimens were cultured for pathogenic bacteria and 267 strains of pathogenic bacteria were detected,of which Gram-positive bacteria accounted for 29.59%,Gram-negative bacteria accounted for 67.04%,and fungi accounted for 3.37%.From 2021 to 2023,the detection rates of Gram-positive bacteria and fungi showed an increasing trend,and Gram-negative bacteria detection rates showed a decreasing trend.Staphylococcus aureus had high sensitivity to linezolid and Staphylococcus epidermidis had high sensitivity to moxifloxacin and linezolid.Escherichia coli and Pseudomonas aeruginosa had high sensitivity to piperacillin/tazobactam,and Klebsiella pneumoniae had high sensitivity to cotrimoxazole,imipenem,and piperacillin/tazobactam.Conclusion The distribution of pathogenic bacteria in patients with hospital-acquired infections admitted to the intensive care unit mainly consisted of Staphylococcus aureus,Staphylococcus epidermidis and Escherichia coli,Pseudomonas aeruginosa,and Klebsiella pneumoniae,and there were varying degrees of resistance to antimicrobial drugs.The subsequent selection of clinical drugs should be cautious,and antimicrobials with high sensitivity should be prioritized.
10.Relationship between clopidogrel resistance and genetic variability in Kawasaki disease children with coronary artery lesions
Yinyin CAO ; Qiyang PAN ; Jian LI ; Xiaofang ZHONG ; Xuecun LIANG ; Lan HE ; Chen CHU ; Quming ZHAO ; Lu ZHAO ; Feng WANG ; Shuna SUN ; Yixiang LIN ; Guoying HUANG ; Fang LIU
Chinese Journal of Pediatrics 2024;62(10):981-988
Objective:To analyze the distribution of clopidogrel metabolism-related gene variability in Kawasaki disease (KD) children with coronary artery lesions (CAL) across different age groups and the impact of genetic variability on the efficacy of clopidogrel antiplatelet therapy.Methods:A retrospective cohort study was conducted. Clinical data were collected from 46 KD children with CAL who were hospitalized in the Cardiovascular Center of Children′s Hospital of Fudan University between January 2021 and August 2022 and were treated with clopidogrel, including gender, age, body mass index, course of KD, CAL severity grade, and baseline platelet count. According to their age, the children were divided into ≥2-year-old group and <2-year-old group. Their platelet responsiveness was assessed by adenosine diphosphate-induced platelet inhibition rate (ADPi) calculated via thromboelastography, and children were categorized into high on-treatment platelet reactivity (HTPR) and normal on-treatment platelet reactivity (NTPR) groups. Genotypes of CYP2C19, PON1 and ABCB1 were detected. The t test, one-way analysis of variance and Chi-square test were used for intergroup comparison. Results:Among the 46 KD children with CAL, 34 were male and 12 were female; 37 were ≥2-year-old and 9 were <2-year-old; 25 cases were in the HTPR group and 21 cases were in the NTPR group, with 19 HTPR and 18 NTPR in the ≥2-year-old group, and 6 HTPR and 3 NTPR in the <2-year-old group. Genetic analysis showed that 92 alleles among the 46 children, with frequencies of CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17, PON1 192Q, PON1 192R, ABCB1 3435C, ABCB1 3435T at 59% (54/92), 32% (29/92), 9% (8/92), 1% (1/92), 36% (36/92), 64% (59/92), 63% (58/92) and 37% (34/92), respectively. Analysis of the impact of genotype on ADPi revealed that in children aged ≥2 years, those with CYP2C19*1/*3 genotype had significantly lower ADPi than those with CYP2C19*1/*1 genotype ((34±15)% vs. (61±29)%, t=2.18, P=0.036). There were also no significant difference in ADPi among children with PON1 192Q homozygous, PON1 192R heterozygote and PON1 192R homozygous genotypes ((40±22)% vs. (52±33)% vs. (65±27)%, F=2.17, P=0.130), or among those with ABCB1 3435C homozygous, ABCB1 3435T heterozygote and ABCB1 3435T homozygous genotypes ((55±34)% vs. (60±27)% vs. (49±24)%, F=0.33, P=0.719). In <2-year-old group, there were no significant differences in ADPi across CYP2C19*1/*1, CYP2C19*1/*2 and CYP2C19*2*2 genotypes ((40±20)% vs. (53±37)% vs. (34±16)%, F=0.37, P>0.05). There were no significant differences in ADPi across CYP2C19*1/*1 and CYP2C19*1/*3 genotypes ((44±27)% vs. (42±20)%, t=0.08, P>0.05). There were no significant differences in ADPi across PON1 192Q homozygous, PON1 192R heterozygote and PON1 192R homozygous genotypes (45% vs. (55±27)% vs. (24±5)%, F=1.83, P>0.05). There were no significant differences in ADPi across ABCB1 3435C homozygous, ABCB1 3435T heterozygote and ABCB1 3435T homozygous genotypes ((36±16)% vs. (50±35)% vs. 45%, F=0.29, P>0.05). The risk analysis of HTPR in different genotypes revealed that in children aged ≥2 years, carrying at least 1 or 2 loss-of-function alleles of CYP2C19 was a risk factor for HTPR ( OR=4.69, 10.00, 95% CI 1.11-19.83, 0.84-119.32, P=0.033, 0.046, respectively), and PON1 192R homozygosity and carrying at least one PON1 192R allele were protective factors against HTPR ( OR=0.08, 0.13, 95% CI 0.01-0.86, 0.01-1.19, P=0.019, 0.043, respectively). Conclusion:KD children aged ≥2 years carrying CYP2C19 loss-of-function alleles and PON1 192Q are more likely to develop HTPR.

Result Analysis
Print
Save
E-mail